Showing 1571-1580 of 20878 results for "".
- Emerging Therapeutics and Molecular Insights in Rheumatoid Arthritishttps://reachmd.com/news/therapeutics-molecular-insights-rheumatoid-arthritis/2484720/The USP5/METTL14/GLUT1 axis has emerged as a molecular pivot that links a deubiquitinase to m6A-mediated control of GLUT1 and drives glycolytic reprogramming with inflammatory activati
- Hepatitis B Birth Dose Timing: Understanding Clinical Impactshttps://reachmd.com/news/hepatitis-b-birth-dose-timing/2484724/New modeling from the Vaccine Integrity Project based at the University of Minnesota projects roughly 99,000 potentially preventable hepatitis B infections through 2050 if routine birth-d
- Mapping Risks: PAD Amputation Trends and New Insights into AFib-OSA Comorbiditieshttps://reachmd.com/news/mapping-risks-pad-amputation-trends-and-new-insights-into-afib-osa-comorbidities/2484710/The PAD Collaborative has released a new interactive amputation map that reveals marked regional disparities in peripheral artery disease (PAD)–related lower-limb amputations, pinpointing geographic hotspots that could guide screening and referral priorities. The
- Regulatory Milestones and Clinical Impact of Otsuka's Voyxact in IgA Nephropathy Treatmenthttps://reachmd.com/news/regulatory-milestones-and-clinical-impact-of-otsukas-voyxact-in-iga-nephropathy-treatment/2484695/The FDA has granted accelerated approval to Otsuka's Voyxact for adults with primary IgA nephropathy (IgAN) at risk f
- Exploring the Role of Compounded Imiquimod in Ocular Surface Cancershttps://reachmd.com/news/exploring-the-role-of-compounded-imiquimod-in-ocular-surface-cancers/2484705/Compounded imiquimod 5% ointment was evaluated in a five-patient interventional case series for ocular surface malignancies, producing focal complete histologi
- Immunization Counseling and Misinformation: Updates from AAPhttps://reachmd.com/news/immunization-counseling-misinformation/2484683/The American Academy of Pediatrics has secured the introduction of CPT codes 90482–90484—an explicit, billable pathway for s
- Revolutionizing Prostate Cancer Diagnosis: The Role of IsoPSA and AIhttps://reachmd.com/news/revolutionizing-prostate-cancer-diagnosis-the-role-of-isopsa-and-ai/2484700/IsoPSA was approved by the FDA as an aid in diagnosing high‑grade prostate cancer and refining
- Enhancing Breast Cancer Detection with Diffusion-Weighted Imaginghttps://reachmd.com/news/breast-cancer-detection-diffusion-weighted-imaging/2484686/A recent study shows that standalone diffusion-weighted imaging (DWI) meaningfully augments AI-based mammography. The study retrospectively analyzed 414 women with pathologic
- Expert Panel Recommends Diversity-Informed Standards for Facial Aesthetic Assessmenthttps://reachmd.com/news/expert-panel-recommends-diversity-informed-standards-for-facial-aesthetic-assessment/2484691/A multidisciplinary panel of dermatologic and aesthetic experts led by American Society for Dermatologic Surgery (ASDS) president Kavita Mariwalla, MD, is calling for a shift away from Western-centric beauty norms toward more culturally inclusive, patient-centric f
- ODAC 2026 Adds Hands-On, High-Impact Workshopshttps://reachmd.com/news/odac-2026-adds-hands-on-high-impact-workshops/2484689/The ODAC Dermatology Conference will return to Orlando, Florida, in 2026 with a refreshed slate of interactive, expert-led sessions that emphasize skill-building across medical, surgical, and aesthetic dermatology, organizers said in a press release. Scheduled for J